Loading data for BAX — first visit, this takes a few seconds.

Baxter International Inc.

NYSE: BAX · Real-Time Price · USD
26.49
+0.15 (0.57%)
At close: Aug 24, 2026, 8:00 PM
26.27
-0.83%
After-hours: 5:35 PM

The price, the headline numbers and the latest news, in one place.

Baxter International Inc. (BAX) Stock Price, Analysis & Data

0.57%

No data available

Bidn/a
Market Cap13.7B
Revenue (ttm)11.47B
Net Income (ttm)-968M
0.59
-1.88
n/a
13.01
P/B (ttm)2.21
P/S (ttm)1.19
Earnings DateOct 29, 2026
Askn/a
Volume4,426,550
Avg. Volume (20D)6,873,314
Open26.37
Previous Close26.34
Day's Range26.07 - 26.61
52-Week Range15.73 - 30.00
Analystn/a
Price Targetn/a
Dividends$0.04 (0.15%)
Ex-Dividend DateAug 28, 2026

About BAX

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant produ...

Sector Healthcare
IPO Date Oct 27, 1981
Employees 37,500
Stock Exchange NYSE
Ticker Symbol BAX
Full Company Profile

Financial Performance

In 2025, Baxter International's revenue was 11.24B, an increase of 5.72% compared to the previous year's 10.64B. Earnings were -957M, an increase of 47.46%.

Financial Statements

Earnings Surprise

Baxter International has released their quarterly earnings on Jul 30, 2026:
  • Revenue of $2.96B misses estimates by $0, with 5.34% YoY growth.
  • EPS of 0.56 exceeds estimates by 0.19, with -5.08% YoY decline.
Baxter International Inc. is scheduled to release its earnings on Oct 29, 2026, before market opens.
Analysts project revenue of ... Upgrade